Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PROFIT & LOSS
Profit & Loss      
Dr. Lal Pathlabs Ltd.
BSE Code 539524
ISIN Demat INE600L01024
Book Value 248.16
NSE Code LALPATHLAB
Dividend Yield % 0.81
Market Cap 246863.84
P/E 56.63
EPS 52.15
Face Value 10  
(Rs. in Millions)
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME:          
Operating Income19668.00  17690.00  18788.00  14906.00  12736.00  
     Income from Medical Services19666.00  17688.00  18787.00  14905.00  12734.00  
     Income from Diagnostic centre          
     Pharmacy / Optical Income          
     Less: Concession / Free Treatment          
     Other Operational Income1.00  2.00  1.00  1.00  2.00  
Less: Excise Duty          
Operating Income (Net)19668.00  17690.00  18788.00  14906.00  12736.00  
EXPENDITURE :          
Increase/Decrease in Stock          
Cost of Medicines and Consumables3908.00  3896.00  4477.00  3739.00  2869.00  
     Opening Raw Materials232.00  390.00  383.00  546.00  268.00  
     Purchases Raw Materials3951.00  3738.00  4484.00  3574.00  3147.00  
     Closing Raw Materials275.00  232.00  390.00  382.00  546.00  
     Other Direct Purchases / Brought in cost          
     Others raw material cost0.00  0.00  0.00  0.00  0.00  
     Other power & fuel0.00  0.00  0.00  0.00  0.00  
Employee Cost3636.00  3155.00  3214.00  2574.00  2321.00  
     Salaries, Wages & Bonus3177.00  2706.00  2680.00  2184.00  1957.00  
     Contributions to EPF & Pension Funds106.00  108.00  110.00  104.00  105.00  
     Workmen and Staff Welfare Expenses84.00  73.00  62.00  43.00  57.00  
     Other Employees Cost268.00  268.00  362.00  243.00  202.00  
Hospital Operation Expenses3928.00  3582.00  3436.00  2493.00  2178.00  
     House Keeping Expenses          
     Consultant / Inhouse Fees3090.00  2803.00  2858.00  2115.00  1816.00  
     Upkeep & Maintainence          
     Sub-contract/ Outsourced services          
     Processing Charges          
     Packing Material Consumed          
     Repairs and Maintenance673.00  639.00  506.00  324.00  308.00  
     Other Operating Expenses165.00  141.00  73.00  54.00  54.00  
Selling, Administration and Other Expenses1929.00  1825.00  1888.00  1471.00  1562.00  
     Rent , Rates & Taxes155.00  140.00  146.00  137.00  139.00  
     Insurance82.00  74.00  66.00  54.00  44.00  
     Printing and stationery122.00  127.00  116.00  84.00  96.00  
     Professional and legal fees97.00  124.00  294.00  125.00  138.00  
     Advertisement & Sales Promotion646.00  427.00  325.00  302.00  332.00  
     Brokerage, Commissions & Incentives          
     Freight outwards          
     Other Administration expenses828.00  934.00  941.00  771.00  815.00  
Miscellaneous Expenses459.00  412.00  452.00  382.00  372.00  
     Bad debts /advances written off3.00  2.00  9.00  1.00  8.00  
     Provision for doubtful debts1.00  15.00    39.00  42.00  
     Losson disposal of fixed assets(net)      2.00    
     Losson foreign exchange fluctuations          
     Losson sale of non-trade current investments          
     Other Miscellaneous Expenses455.00  394.00  443.00  340.00  322.00  
Less: Expenses Capitalised          
Total Expenditure14075.00  13083.00  13663.00  10832.00  9458.00  
Operating Profit (Excl OI)5592.00  4607.00  5125.00  4074.00  3278.00  
Other Income601.00  466.00  531.00  513.00  576.00  
     Interest Received447.00  275.00  449.00  427.00  438.00  
     Dividend Received32.00  120.00  16.00  16.00  47.00  
     Profit on sale of Fixed Assets3.00  15.00  3.00    1.00  
     Profits on sale of Investments        79.00  
     Foreign Exchange Gains          
     Provision Written Back    37.00  5.00  1.00  
     Others118.00  56.00  27.00  65.00  8.00  
Operating Profit6193.00  5073.00  5656.00  4586.00  3854.00  
Interest268.00  344.00  286.00  148.00  147.00  
     InterestonDebenture / Bonds          
     Interest on Term Loan90.00  119.00  12.00      
     Intereston Fixed deposits          
     Bank Charges etc          
     Other Interest179.00  225.00  274.00  148.00  147.00  
PBDT5925.00  4729.00  5369.00  4438.00  3708.00  
Depreciation765.00  821.00  759.00  698.00  680.00  
Profit Before Taxation & Exceptional Items5160.00  3908.00  4610.00  3740.00  3028.00  
Exceptional Income / Expenses          
Profit Before Tax5160.00  3908.00  4610.00  3740.00  3028.00  
Provision for Tax1316.00  985.00  1157.00  939.00  796.00  
     Current Income Tax1376.00  1015.00  1215.00  984.00  802.00  
     Deferred Tax-60.00  -43.00  -53.00  -45.00  -7.00  
Share of Associate          
Other Consolidated Items          
Consolidated Net Profit3844.00  2924.00  3453.00  2801.00  2232.00  
Adjustments to PAT          
Profit Balance B/F13787.00  11838.00  9556.00  7736.00  7049.00  
Appropriations17630.00  14761.00  13008.00  10537.00  9281.00  
     General Reserves          
     Proposed Equity Dividend          
     Corporate dividend tax        201.00  
     Other Appropriation501.00  478.00  13.00  7.00  355.00  
Equity Dividend %240.00  120.00  120.00  200.00  120.00  
Earnings Per Share46.00  35.00  41.00  34.00  27.00  
Adjusted EPS46.00  35.00  41.00  34.00  27.00  
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.